Literature DB >> 22162514

Regional differences in the evolution of lung disease in children with cystic fibrosis.

Zhanhai Li1, Don B Sanders, Michael J Rock, Michael R Kosorok, Jannette Collins, Christopher G Green, Alan S Brody, Philip M Farrell.   

Abstract

Progression of lung disease is a major event in children with cystic fibrosis (CF), but regional differences in its evolution are unclear. We hypothesized that regional differences occur beginning in early childhood. We examined this issue by evaluating 132 patients followed in the Wisconsin Neonatal Screening Project between 1985 and 2010. We scored chest X-rays obtained every 1-2 years with the Wisconsin chest X-ray system, in which we divided the lungs into quadrants, and gave special attention to ratings for bronchiectasis (BX) and nodular/branching opacities. We compared the upper and lower quadrant scores, and upper right and left quadrant scores, as patients aged using a multivariable generalized estimation equation (GEE) model. We did a confirmatory analysis for a subset of 81 patients with chest computerized tomography (CT) images obtained in 2000 and scored using the Brody scoring system. The chest X-ray analysis shows that the upper quadrants have higher BX (P<0.001) and nodular/branching opacities (P<0.001) scores than the lower quadrants. CT analysis likewise reveals that the upper quadrants have more BX (P=0.02). Patients positive for mucoid PA showed significantly higher BX scores than patients with non-mucoid PA (P=0.001). Chest X-ray scoring also revealed that the upper right quadrant has more BX (P<0.001) than the upper left quadrant, and CT analysis was again confirmatory (P<0.001). We conclude that pediatric patients with CF develop more severe lung disease in the upper lobes than the lower lobes in association with mucoid PA infections and also have more severe lung disease on the right side than on the left side in the upper quadrants. A variety of potential explanations such as aspiration episodes may be clinically relevant and provide insights regarding therapies.
Copyright © 2011 Wiley Periodicals, Inc.

Entities:  

Mesh:

Year:  2011        PMID: 22162514      PMCID: PMC3310260          DOI: 10.1002/ppul.21604

Source DB:  PubMed          Journal:  Pediatr Pulmonol        ISSN: 1099-0496


  20 in total

Review 1.  Management of pulmonary disease in patients with cystic fibrosis.

Authors:  B W Ramsey
Journal:  N Engl J Med       Date:  1996-07-18       Impact factor: 91.245

2.  Regional distribution of macroscopic lung disease in cystic fibrosis.

Authors:  J F Tomashefski; M Bruce; H I Goldberg; D G Dearborn
Journal:  Am Rev Respir Dis       Date:  1986-04

3.  Diagnostic accuracy of oropharyngeal cultures in infants and young children with cystic fibrosis.

Authors:  M Rosenfeld; J Emerson; F Accurso; D Armstrong; R Castile; K Grimwood; P Hiatt; K McCoy; S McNamara; B Ramsey; J Wagener
Journal:  Pediatr Pulmonol       Date:  1999-11

4.  Bronchoscopy in cystic fibrosis infants diagnosed by newborn screening.

Authors:  Patrick Stafler; Jane C Davies; Ian M Balfour-Lynn; Mark Rosenthal; Andrew Bush
Journal:  Pediatr Pulmonol       Date:  2011-03-01

5.  Early diagnosis of cystic fibrosis through neonatal screening prevents severe malnutrition and improves long-term growth. Wisconsin Cystic Fibrosis Neonatal Screening Study Group.

Authors:  P M Farrell; M R Kosorok; M J Rock; A Laxova; L Zeng; H C Lai; G Hoffman; R H Laessig; M L Splaingard
Journal:  Pediatrics       Date:  2001-01       Impact factor: 7.124

6.  Improving the health of patients with cystic fibrosis through newborn screening. Wisconsin Cystic Fibrosis Neonatal Screening Study Group.

Authors:  P M Farrell
Journal:  Adv Pediatr       Date:  2000

7.  Early pulmonary inflammation in infants with cystic fibrosis.

Authors:  T Z Khan; J S Wagener; T Bost; J Martinez; F J Accurso; D W Riches
Journal:  Am J Respir Crit Care Med       Date:  1995-04       Impact factor: 21.405

8.  High resolution computed tomography in adult cystic fibrosis patients with mild lung disease.

Authors:  G Santis; M E Hodson; B Strickland
Journal:  Clin Radiol       Date:  1991-07       Impact factor: 2.350

9.  Chest physiotherapy in infants with cystic fibrosis: to tip or not? A five-year study.

Authors:  Brenda M Button; Ralf G Heine; Anthony G Catto-Smith; Anthony Olinsky; Peter D Phelan; Michael R Ditchfield; Ian Story
Journal:  Pediatr Pulmonol       Date:  2003-03

10.  Wisconsin cystic fibrosis chest radiograph scoring system.

Authors:  M R Weatherly; C G Palmer; M E Peters; C G Green; D Fryback; R Langhough; P M Farrell
Journal:  Pediatrics       Date:  1993-02       Impact factor: 7.124

View more
  11 in total

1.  A Flow Cytometric Method for Isolating Cystic Fibrosis Airway Macrophages from Expectorated Sputum.

Authors:  Katherine B Hisert; W Conrad Liles; Anne M Manicone
Journal:  Am J Respir Cell Mol Biol       Date:  2019-07       Impact factor: 6.914

2.  Mucoid Pseudomonas aeruginosa and regional inflammation in the cystic fibrosis lung.

Authors:  Sankalp Malhotra; Don Hayes; Daniel J Wozniak
Journal:  J Cyst Fibros       Date:  2019-04-26       Impact factor: 5.482

Review 3.  Cystic Fibrosis and Pseudomonas aeruginosa: the Host-Microbe Interface.

Authors:  Sankalp Malhotra; Don Hayes; Daniel J Wozniak
Journal:  Clin Microbiol Rev       Date:  2019-05-29       Impact factor: 26.132

4.  Preliminary comparison of normalized T1 and non-contrast perfusion MRI assessments of regional lung disease in cystic fibrosis patients.

Authors:  Shannon B Donnola; Elliott C Dasenbrook; David Weaver; Lan Lu; Karishma Gupta; Anjali Prabhakaran; Xin Yu; James F Chmiel; Kimberly McBennett; Michael W Konstan; Mitchell L Drumm; Chris A Flask
Journal:  J Cyst Fibros       Date:  2015-12-22       Impact factor: 5.482

Review 5.  Novel end points for clinical trials in young children with cystic fibrosis.

Authors:  Shannon J Simpson; Lauren S Mott; Charles R Esther; Stephen M Stick; Graham L Hall
Journal:  Expert Rev Respir Med       Date:  2013-06       Impact factor: 3.772

6.  Cheating by type 3 secretion system-negative Pseudomonas aeruginosa during pulmonary infection.

Authors:  Kamila Czechowska; Saria McKeithen-Mead; Khatoun Al Moussawi; Barbara I Kazmierczak
Journal:  Proc Natl Acad Sci U S A       Date:  2014-05-12       Impact factor: 11.205

7.  Sensitive structural and functional measurements and 1-year pulmonary outcomes in pediatric cystic fibrosis.

Authors:  Matthew M Willmering; David J Roach; Elizabeth L Kramer; Laura L Walkup; Zackary I Cleveland; Jason C Woods
Journal:  J Cyst Fibros       Date:  2020-12-04       Impact factor: 5.482

8.  Association between spirometry controlled chest CT scores using computer-animated biofeedback and clinical markers of lung disease in children with cystic fibrosis.

Authors:  Thomas Kongstad; Kent Green; Frederik Buchvald; Marianne Skov; Tania Pressler; Kim Gjerum Nielsen
Journal:  Eur Clin Respir J       Date:  2017-05-02

9.  Normalized T1 magnetic resonance imaging for assessment of regional lung function in adult cystic fibrosis patients--a cross-sectional study.

Authors:  Elliott C Dasenbrook; Lan Lu; Shannon Donnola; David E Weaver; Vikas Gulani; Peter M Jakob; Michael W Konstan; Chris A Flask
Journal:  PLoS One       Date:  2013-09-25       Impact factor: 3.240

10.  Analysis of Lung Microbiota in Bronchoalveolar Lavage, Protected Brush and Sputum Samples from Subjects with Mild-To-Moderate Cystic Fibrosis Lung Disease.

Authors:  Deborah A Hogan; Sven D Willger; Emily L Dolben; Thomas H Hampton; Bruce A Stanton; Hilary G Morrison; Mitchell L Sogin; Julianna Czum; Alix Ashare
Journal:  PLoS One       Date:  2016-03-04       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.